Tag Archives: Side Effects

Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Posted on October 28, 2024 by cchrstl

Decades after sexual dysfunction caused by antidepressants was first reported to persist after patients stopped taking the drugs, how many people experience continuing sexual problems is still not known.  Citizens Commission on Human Rights calls on the FDA to address the issue without further delay.  Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Clozapine (Really?) for Schizophrenia

Posted on October 21, 2024 by cchrstl

Psychiatric drugs and psychiatric treatments are not workable. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on Clozapine (Really?) for Schizophrenia

CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

Posted on September 2, 2024 by cchrstl

Evidence presented to the U.S. drug regulatory agency alleging sexual assault and suppression of adverse events in clinical trials of ecstasy raises urgent concerns about the safety of patients in psychedelic-assisted psychotherapy. Citizens Commission on Human Rights calls for public release of FDA investigation results. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Comments Off on CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

Posted on August 19, 2024 by cchrstl

The U.S. drug regulatory agency examined evidence presented by the company requesting approval for MDMA (ecstasy) and reports from experts examining that evidence before denying approval for the drug as mental health treatment. A medical journal has just retracted three MDMA therapy research papers for ethical violations. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , | Comments Off on CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

Mothers’ Psychiatric Drug Use Increases Risk of Newborns Needing Urgent Medical Attention, New Research Finds

Posted on July 1, 2024 by cchrstl

Expectant mothers considering psychiatric drugs should have the increased risks of premature birth and respiratory, circulatory, and feeding problems for their newborns fully disclosed to them by their prescribers. Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Comments Off on Mothers’ Psychiatric Drug Use Increases Risk of Newborns Needing Urgent Medical Attention, New Research Finds

CCHR Calls Attention to New Research Finding More Serious Risks to Elderly Dementia Patients from Antipsychotic Drugs

Posted on June 24, 2024 by cchrstl

Citizens Commission on Human Rights calls for government action to make prescribers and caregivers of the elderly aware of the wider range of serious risks to dementia patients from antipsychotic drugs and to curtail the wrongful use of the drugs. Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Comments Off on CCHR Calls Attention to New Research Finding More Serious Risks to Elderly Dementia Patients from Antipsychotic Drugs

CCHR Applauds FDA Advisory Committee Rejection of Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress

Posted on June 17, 2024 by cchrstl

Committee’s recommendation to reject as therapy the psychedelic drug MDMA, also known as the “date rape” drug Ecstasy, comes after evidence from clinical trials was deemed insufficient to establish safety or effectiveness. Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on CCHR Applauds FDA Advisory Committee Rejection of Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress

Push for Use of Psychedelic Drugs as Mental Health Treatment Downplays Dangerous Risks, Citizens Commission on Human Rights Says in Protest

Posted on June 10, 2024 by cchrstl

It is not known how psychedelic drugs are supposed to work as mental health treatment. Psychedelics carry the risks of devastating immediate and long-term harms, putting human lives and sanity at risk. Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on Push for Use of Psychedelic Drugs as Mental Health Treatment Downplays Dangerous Risks, Citizens Commission on Human Rights Says in Protest

CCHR Commends Lawsuit Filed over FDA’s Failure to Act on Citizen Petition to Update Antidepressant Labeling for Persistent Sexual Problems

Posted on June 3, 2024 by cchrstl

Research has long indicated that antidepressant users are at risk of serious sexual problems that may persist indefinitely, even after stopping the drugs. Citizens Commission on Human Rights says FDA needs to act now. Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on CCHR Commends Lawsuit Filed over FDA’s Failure to Act on Citizen Petition to Update Antidepressant Labeling for Persistent Sexual Problems

CCHR Calls Attention to New Reports on Risks of Antipsychotic Drugs, Including Loss of Self-Identity

Posted on May 6, 2024 by cchrstl

How antipsychotic drugs are used is challenged by research reporting on the negative effect on patients’ sense of self and on the possibility of worse social functioning and quality of life from long-term use for some patients. Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on CCHR Calls Attention to New Reports on Risks of Antipsychotic Drugs, Including Loss of Self-Identity